SYS-CON MEDIA Authors: Mat Mathews, PR.com Newswire, David Smith, Tim Crawford, Kevin Benedict

News Feed Item

MEDIA ADVISORY: Vancouver Researchers Aim to Revolutionize COPD Treatment

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 11/29/13 -- Genome British Columbia is pleased to announce a significant advance in the treatment of Chronic Obstructive Pulmonary Disease (COPD.) This serious lung condition affects 3 million Canadians and costs the Canadian healthcare system nearly $4 billion annually. By applying the power of genomics, this new research project partnership capitalizes on BC-based expertise and novel technology.

Learn how genomics is changing the way we treat COPD.


WHAT     An opportunity to interview the researchers and funder behind this
         innovative project

WHEN     Interviews available Wednesday, December 4th from 10:00am to 3:00pm
         and by appointment

WHERE    Sheraton Wall Centre Hotel
         Pavilion Ballroom
         1088 Burrard St.
         Vancouver
WHO
 - Mr. Dick Vollett, President & CEO, St. Paul's Hospital Foundation
 - Dr. Alan Winter, President & CEO, Genome BC
 - Dr. Don Sin, Project Lead, Professor of Medicine at the University of
   British Columbia and a respirologist at St. Paul's Hospital
 - Dr. Jerry Sandbrand, COPD patient

B-Roll video and still photos of Dr. Sin in his laboratory and clinic are available.

About Genome British Columbia:

Genome British Columbia is a catalyst for the life sciences cluster on Canada's West Coast, and manages a cumulative portfolio of over $625M in research projects and science and technology platforms. Working with governments, academia and industry across sectors such as forestry, fisheries, agriculture, environment, bioenergy, mining and human health, the goal of the organization is to generate social and economic benefits for British Columbia and Canada. Genome BC is supported by the Province of British Columbia, the Government of Canada through Genome Canada and Western Economic Diversification Canada and more than 300 international public and private co-funding partners. www.genomebc.ca

More Stories By Marketwired .

Copyright ┬ę 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.